Abstract
Comorbidities associated with psoriatic arthritis (PsA) include cardiovascular diseases, diabetes mellitus, and obesity. This study evaluated the association between PsA and common gastrointestinal (GI) diseases. A retrospective study was performed in Israel’s largest health care provider database between 2002 and 2013. 3161 PsA patients were matched for age and sex with 31610 randomly selected patients. We searched these patients’ records for the presence of peptic ulcer disease (PUD), reflux esophagitis, Crohn’s disease, ulcerative colitis, irritable bowel syndrome (IBS) and celiac disease. T-test was used to compare continuous variables and a Chi-square test was used for categorical variables. Multivariate logistic regression models were used to assess the association between PsA and GI comorbidities. PsA was associated with Crohn’s disease (OR 2.4, 95 %CI: 1.75–3.32, p < 0.0001), ulcerative colitis (OR 2.1, 95 %CI: 1.33–3.26, p = 0.001), reflux esophagitis (OR 1.6, 95 %CI: 1.44–1.78, p < 0.0001), PUD (OR 1.5, 95 %CI: 1.31–1.63, p < 0.0001) and IBS (OR 1.4, 95 %CI: 1.01–1.86, p = 0.045). After controlling for known risk factors, the association remained significant between PsA and Crohn’s disease (OR 2.2, 95 %CI: 1.59–3.03, p < 0.0001), ulcerative colitis (OR 1.9, 95 %CI: 1.21–3.00, p = 0.005), reflux esophagitis (OR 1.5, 95 %CI: 1.31–1.63, p < 0.0001), and PUD (OR 1.3, 95 %CI: 1.12–1.47, p < 0.0001). No significant association was found between PsA and celiac disease. In the current study PsA was associated with gastrointestinal morbidities including Crohn’s disease, ulcerative colitis, PUD and IBS. Physicians treating patients with PsA should be aware of these associations.
Similar content being viewed by others
References
Armstrong EJ, Harskamp CT, Armstrong AW (2013) Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2:e000062. doi:10.1161/JAHA.113.000062
Oliveira M de FSP de, Rocha B de O, Duarte GV (2015) Psoriasis: classical and emerging comorbidities. Ann Bras Dermatol 90:9–20. doi: 10.1590/abd1806–4841.20153038
Shapiro J, Cohen AD, David M, et al. (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 56:629–634. doi:10.1016/j.jaad.2006.09.017
Armstrong AW, Harskamp CT, Armstrong EJ (2013) Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 149:84–91. doi:10.1001/2013.jamadermatol.406
Ogdie A, Schwartzman S, Eder L, et al. (2014) Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations. J Rheumatol 41:2315–2322. doi:10.3899/jrheum.140882
Helliwell PS (2004) Relationship of psoriatic arthritis with the other spondyloarthropathies. Curr Opin Rheumatol 16:344–349
Rudwaleit M, Baeten D (2006) Ankylosing spondylitis and bowel disease. Best Practice & Research Clinical Rheumatology 20:451–471. doi:10.1016/j.berh.2006.03.010
Levine JS, Burakoff R (2011) Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 7:235–241
Binus AM, Han J, Qamar AA, et al. (2012) Associated comorbidities in psoriasis and inflammatory bowel disease. J Eur Acad Dermatol Venereol 26:644–650. doi:10.1111/j.1468-3083.2011.04153.x
Barnas JL, Ritchlin CT (2015) Etiology and pathogenesis of psoriatic arthritis. Rheum Dis Clin N Am 41:643–663. doi:10.1016/j.rdc.2015.07.006
Ciccia F, Guggino G, Ferrante A, et al. (2016) Interleukin-9 overexpression and Th9 polarization characterize the inflamed gut, the synovial tissue, and the peripheral blood of patients with psoriatic arthritis. Arthritis & Rheumatology (Hoboken, NJ) 68:1922–1931. doi:10.1002/art.39649
Wohl Y, Dreiher J, Cohen AD (2010) Pemphigus and osteoporosis: a case-control study. Arch Dermatol 146:1126–1131. doi:10.1001/archdermatol.2010.257
Cohen AD, Weitzman D, Birkenfeld S, Dreiher J (2010) Psoriasis associated with hepatitis C but not with hepatitis B. Dermatology (Basel) 220:218–222. doi:10.1159/000286131
Dreiher J, Kresch FS, Comaneshter D, Cohen AD (2012) Risk of herpes zoster in patients with psoriasis treated with biologic drugs. J Eur Acad Dermatol Venereol 26:1127–1132. doi:10.1111/j.1468-3083.2011.04230.x
Zisman D, Bitterman H, Shalom G, et al. (2014) Psoriatic arthritis treatment and the risk of herpes zoster. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-205148
Liu J-T, Yeh H-M, Liu S-Y, Chen K-T (2014) Psoriatic arthritis: epidemiology, diagnosis, and treatment. World J Orthop 5:537–543. doi:10.5312/wjo.v5.i4.537
Russolillo A, Iervolino S, Peluso R, et al. (2013) Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford) 52:62–67. doi:10.1093/rheumatology/kes242
Cañete JD, Mease P (2012) The link between obesity and psoriatic arthritis. Ann Rheum Dis 71:1265–1266. doi:10.1136/annrheumdis-2012-201632
Makredes M, Robinson D, Bala M, Kimball AB (2009) The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol 61:405–410. doi:10.1016/j.jaad.2009.02.015
Perez-Alamino R, Maldonado-Ficco H, Maldonado-Cocco JA (2015) Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol. doi:10.1007/s10067-015-3116-6
Scher JU, Ubeda C, Artacho A, et al. (2015) Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis & Rheumatology (Hoboken, NJ) 67:128–139. doi:10.1002/art.38892
Tamboli CP, Neut C, Desreumaux P, Colombel JF (2004) Dysbiosis in inflammatory bowel disease. Gut 53:1–4
Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349
Mielants H, Veys EM, De Vos M, et al. (1995) The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 22:2266–2272
Mielants H, Veys EM, Cuvelier C, et al. (1995) The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22:2273–2278
Mielants H, Veys EM, Cuvelier C, et al. (1995) The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 22:2279–2284
Schatteman L, Mielants H, Veys EM, et al. (1995) Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. J Rheumatol 22:680–683
Bandinelli F, Manetti M, Ibba-Manneschi L (2016) Occult spondyloarthritis in inflammatory bowel disease. Clin Rheumatol 35:281–289. doi:10.1007/s10067-015-3074-z
Teahon K, Smethurst P, Levi AJ, et al. (1992) Intestinal permeability in patients with Crohn’s disease and their first degree relatives. Gut 33:320–323
Vaile JH, Meddings JB, Yacyshyn BR, et al. (1999) Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 26:128–135
Li W-Q, Han J-L, Chan AT, Qureshi AA (2013) Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis 72:1200–1205. doi:10.1136/annrheumdis-2012-202143
Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD (2011) Gastrointestinal manifestations in systemic autoimmune diseases. Maedica (Buchar) 6:45–51
Pellicano R (2014) Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations. Minerva Gastroenterol Dietol 60:255–261
Mertz HR, Walsh JH (1991) Peptic ulcer pathophysiology. Med Clin North Am 75:799–814
Szodoray P, Alex P, Chappell-Woodward CM, et al. (2007) Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology (Oxford) 46:417–425. doi:10.1093/rheumatology/kel306
Iqbal T, Zaidi MA, Wells GA, Karsh J (2013) Celiac disease arthropathy and autoimmunity study. J Gastroenterol Hepatol 28:99–105. doi:10.1111/j.1440-1746.2012.07272.x
Lauret E, Rodrigo L (2013) Celiac disease and autoimmune-associated conditions. Biomed Res Int. doi:10.1155/2013/127589
Ludvigsson JF, Lindelöf B, Zingone F, Ciacci C (2011) Psoriasis in a nationwide cohort study of patients with celiac disease. J Invest Dermatol 131:2010–2016. doi:10.1038/jid.2011.162
Ojetti V, Aguilar Sanchez J, Guerriero C, et al. (2003) High prevalence of celiac disease in psoriasis. Am J Gastroenterol 98:2574–2575. doi:10.1111/j.1572-0241.2003.08684.x
Lubrano E, Iovino P, Tremolaterra F, et al. (2001) Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. Int J Color Dis 16:211–215
Salaffi F, De Angelis R, Carotti M, et al. (2014) Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 34:1103–1110. doi:10.1007/s00296-014-2955-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interest.
Additional information
Ariel Zohar and Arnon Dov Cohen contributed equally to the manuscript.
Rights and permissions
About this article
Cite this article
Zohar, A., Cohen, A.D., Bitterman, H. et al. Gastrointestinal comorbidities in patients with psoriatic arthritis. Clin Rheumatol 35, 2679–2684 (2016). https://doi.org/10.1007/s10067-016-3374-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3374-y